Healthcare News of Note: Advocate Aurora Health and Atrium Health megamerger complete
Healthcare News of Note for healthcare finance professionals is a roundup of recent news articles: Atrium and Advocate Health close merger deal, CMS details expectations of hospitals in memo addressing workplace violence, and CMS plans to recoup $650 million in overpayments to Medicare Advantage plans.
CY 2023 Physician Fee Schedule Final Rule Summary Part II – Medicare Shared Savings Program Requirements
HFMA presents Part II of three detailed summaries of the final rule relating to the Medicare physician fee schedule for CY 2023 and other revisions to Medicare Part B policies. Part II covers the Medicare Shared Savings Program Requirements.
CY 2023 Physician Fee Schedule Final Rule Summary Part I
HFMA presents Part I of three detailed summaries of the final rule relating to the Medicare physician fee schedule for CY 2023 and other revisions to Medicare Part B policies.
CY 2023 End-Stage Renal Disease Prospective Payment System Final Rule Summary
HFMA presents a detailed summary of the CY 2023 final rule addressing routine payment updates to the Medicare End Stage Renal Disease Prospective Payment System.
Why it can be a good idea for hospitals to stand up to government policy
Healthcare finance executives in the United States can take a lesson from an eye-opening book by Ted Giovanis, FHFMA, MBA, Beyond fear: How I fought the feds for six years — and won. In this book, Giovanis, a long-standing member of HFMA’s Maryland Chapter, chronicles how he identified an error in an arcane Medicare formula…
Final regulations for rural emergency hospitals set the stage for first year of eligibility
REHs will be reimbursed for providing emergency care and outpatient services and must abide by terms and conditions that include limiting average length of stay to 24 hours.
Changes to reimbursement for 340B drugs reverberate in the 2023 final rule for Medicare outpatient payments
The Medicare payment rate for hospital outpatient services will increase significantly in 2023, but the net gain will be quite a bit less than is apparent at first glance.
Paul Keckley: 2 major changes in the value agenda require finance leaders’ attention
The value agenda in U.S. healthcare is critical to its future, but there are two key areas in which it is likely to be redirected in years to come.
Rethinking population health management: Why successful risk-based contracting requires provider empowerment
Find out how one company hopes to solve challenges of industry shifts from fee-for-service to value-based care by reversing the long-standing narrative that population health management isn’t possible or profitable.
Medicare payments for 340B drugs are set to increase immediately after recent court ruling
The Medicare payment rate for drugs acquired through the 340B program must be increased by nearly 30 percentage points effective immediately, according to a court ruling.